During the past decade, Headlands Research - Brownsville conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Headlands Research - Brownsville" are "Alzheimer Disease" (1 trials), "COVID-19" (1 trials) and "Influenza, Human" (1 trials). Many other conditions were trialed in "Headlands Research - Brownsville" in a lesser frequency.

Most popular intervention types in "Headlands Research - Brownsville" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Donanemab" (1 trials), "Placebo" (1 trials), "Quadrivalent influenza modRNA vaccine" (1 trials), "Quadrivalent influenza vaccine" (1 trials) and "nirmatrelvir" (1 trials). Other intervention names were less common.

The vast majority of trials in "Headlands Research - Brownsville" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Headlands Research - Brownsville". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Headlands Research - Brownsville, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Headlands Research - Brownsville, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".